Works matching DE "DARBEPOETIN alfa"
Results: 84
Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial).
- Published in:
- Clinical & Experimental Nephrology, 2018, v. 22, n. 1, p. 78, doi. 10.1007/s10157-017-1427-4
- By:
- Publication type:
- Article
Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial).
- Published in:
- Clinical & Experimental Nephrology, 2016, v. 20, n. 1, p. 71, doi. 10.1007/s10157-015-1133-z
- By:
- Publication type:
- Article
Pharmacokinetics of darbepoetin alfa after single, intravenous or subcutaneous administration in Japanese pediatric patients with chronic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2014, v. 18, n. 6, p. 932, doi. 10.1007/s10157-014-0936-7
- By:
- Publication type:
- Article
Effects of three kinds of erythropoiesis-stimulating agents on renal anemia in Japanese non-dialysis chronic kidney disease patients.
- Published in:
- Clinical & Experimental Nephrology, 2014, v. 18, n. 5, p. 755, doi. 10.1007/s10157-013-0919-0
- By:
- Publication type:
- Article
Efficacy and safety of darbepoetin alfa for anemia in children with chronic kidney disease: a multicenter prospective study in Japan.
- Published in:
- Clinical & Experimental Nephrology, 2014, v. 18, n. 4, p. 634, doi. 10.1007/s10157-013-0859-8
- By:
- Publication type:
- Article
Darbepoetin alfa for the treatment of anemia in children undergoing peritoneal dialysis: a multicenter prospective study in Japan.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 4, p. 582, doi. 10.1007/s10157-012-0714-3
- By:
- Publication type:
- Article
Different administration schedules of darbepoetin alfa affect oxidized and reduced glutathione levels to a similar extent in 5/6 nephrectomized rats.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 4, p. 569, doi. 10.1007/s10157-012-0749-5
- By:
- Publication type:
- Article
Comparing the efficacy of continuous erythropoietin receptor activator and darbepoetin Alfa treatments in Japanese patients with chronic kidney disease during the predialysis period: A propensity-matched analysis.
- Published in:
- Nephrology, 2015, v. 20, p. 22, doi. 10.1111/nep.12641
- By:
- Publication type:
- Article
Frequency of Administration of Erythropoiesis-Stimulating Agents for the Anaemia of End-Stage Kidney Disease in Dialysis.
- Published in:
- Nephrology, 2015, v. 20, n. 9, p. 663, doi. 10.1111/nep.12438
- Publication type:
- Article
Darbepoetin alfa once monthly corrects anaemia in patients with chronic kidney disease not on dialysis.
- Published in:
- Nephrology, 2014, v. 19, n. 5, p. 266, doi. 10.1111/nep.12214
- By:
- Publication type:
- Article
Dosing regimen and tolerability of methoxy polyethylene glycol-epoetin beta in Chinese dialysis patients.
- Published in:
- Nephrology, 2013, v. 18, n. 8, p. 533, doi. 10.1111/nep.12105
- By:
- Publication type:
- Article
Managing chemotherapy induced anemia with darbepoetin alfa and other erythropoiesis stimulating agents: a nurse's perspective.
- Published in:
- Nursing: Research & Reviews, 2013, v. 3, p. 155, doi. 10.2147/NRR.S49399
- By:
- Publication type:
- Article
Chemotherapy-related anemia.
- Published in:
- 2018
- By:
- Publication type:
- Letter
High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 5, p. 621, doi. 10.1007/s00277-013-1686-4
- By:
- Publication type:
- Article
Erratum to: High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM.
- Published in:
- 2013
- By:
- Publication type:
- Correction Notice
Efficacy of once or twice weekly administration of epoetin κ in patients receiving hemodialysis: A retrospective study.
- Published in:
- Experimental & Therapeutic Medicine, 2014, v. 7, n. 1, p. 27, doi. 10.3892/etm.2013.1384
- By:
- Publication type:
- Article
Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The comparative effects of recombinant human erythropoietin and darbepoetin-alpha on cerebral vasospasm following experimental subarachnoid hemorrhage in the rabbit.
- Published in:
- Acta Neurochirurgica, 2014, v. 156, n. 5, p. 951, doi. 10.1007/s00701-014-2008-x
- By:
- Publication type:
- Article
Effects of darbepoetin-alpha in spinal cord ischemia-reperfusion injury in the rabbit.
- Published in:
- Acta Neurochirurgica, 2012, v. 154, n. 6, p. 1037, doi. 10.1007/s00701-012-1298-0
- By:
- Publication type:
- Article
The efficiency of fatty acids, N-acetyl-D-mannosamine, and N-acetylneuraminic acid for a change in the sialylation profile of recombinant darbepoetin alfa in CHO cell culture.
- Published in:
- Applied Biochemistry & Microbiology, 2015, v. 51, n. 8, p. 827, doi. 10.1134/S0003683815080049
- By:
- Publication type:
- Article
Optimization of genetic constructs for high-level expression of the darbepoetin gene in mammalian cells.
- Published in:
- Applied Biochemistry & Microbiology, 2014, v. 50, n. 9, p. 802, doi. 10.1134/S0003683814090051
- By:
- Publication type:
- Article
Design of a stable cell line producing recombinant darbepoetin alpha based on CHO cells.
- Published in:
- Applied Biochemistry & Microbiology, 2014, v. 50, n. 9, p. 812, doi. 10.1134/S0003683814090063
- By:
- Publication type:
- Article
Anaemia of renal disease: pathophysiology and treatment updates.
- Published in:
- UK-Vet Companion Animal, 2015, v. 20, n. 8, p. 448, doi. 10.12968/coan.2015.20.8.448
- By:
- Publication type:
- Article
Efficacy and safety of darbepoetin alfa initiated at hemoglobin ≤10 g/dL in patients with stage IV cancer and chemotherapy-induced anemia.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 12, p. 3445, doi. 10.1002/cam4.958
- By:
- Publication type:
- Article
Efficacy and safety of CKD-11101 (darbepoetin-alfa proposed biosimilar) compared with NESP in anaemic chronic kidney disease patients not on dialysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A prospective cohort study on the impact of darbepoetin alfa on quality of life in daily practice following anemia treatment guideline revisions.
- Published in:
- Current Medical Research & Opinion, 2014, v. 30, n. 9, p. 1813, doi. 10.1185/03007995.2014.924914
- By:
- Publication type:
- Article
Single Dose Darbepoetin Alfa is Useful in Reducing Red Cell Transfusions in Leukemic Children Receiving Chemotherapy.
- Published in:
- Pediatric Hematology & Oncology, 2014, v. 31, n. 5, p. 442, doi. 10.3109/08880018.2013.824527
- By:
- Publication type:
- Article
Late-onset Erythropoietic Protoporphyria Associated with Myelodysplastic Syndrome Treated with Azacitidine.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Hemoglobin levels and quality of life in patients with symptomatic chemotherapy-induced anemia: the eAQUA study.
- Published in:
- Cancer Management & Research, 2016, v. 8, p. 1, doi. 10.2147/CMAR.S88110
- By:
- Publication type:
- Article
Darbepoetin alfa: A new therapeutic agent for renal anemia.
- Published in:
- Kidney International, 2002, v. 61, p. S55, doi. 10.1046/j.1523-1755.61.s80.11.x
- By:
- Publication type:
- Article
Efficacy and safety of darbepoetin alpha in patients with myelodysplastic syndromes: a systematic review and meta-analysis.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 5, p. 730, doi. 10.1111/bjh.14116
- By:
- Publication type:
- Article
Oral Daprodustat Treats Anemia in Chronic Kidney Disease.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A combined model of human erythropoiesis and granulopoiesis under growth factor and chemotherapy treatment.
- Published in:
- Theoretical Biology & Medical Modelling, 2014, v. 11, n. 1, p. 2, doi. 10.1186/1742-4682-11-24
- By:
- Publication type:
- Article
Outcomes in patients with chronic kidney disease not on dialysis receiving extended dosing regimens of darbepoetin alfa: long-term results of the EXTEND observational cohort study.
- Published in:
- Nephrology Dialysis Transplantation, 2016, v. 31, n. 12, p. 2073, doi. 10.1093/ndt/gfw047
- By:
- Publication type:
- Article
Effects of Darbepoetin-alpha on Plasma Pro-inflammatory Cytokines and Soluble Fas/Fas Ligand System in Anemic Patients with Chronic Heart Failure
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Effects of Darbepoetin-alpha on quality of life and emotional stress in anemic patients with chronic heart failure
- Published in:
- 2008
- By:
- Publication type:
- Abstract
561 Pharmacokinetic-pharmacodynamic modeling and simulation of darbepoetin alfa once-monthly dosing regimen for the design of clinical trials in anemic patients with chronic heart failure
- Published in:
- 2006
- By:
- Publication type:
- Abstract
549 Randomized, double-blind, placebo-controlled trial to assess the impact of darbepoetin alfa treatment on exercise tolerance in anemic patients with symptomatic heart failure: results from STAMINA-HeFT
- Published in:
- 2006
- By:
- Publication type:
- Abstract
548 The effect of darbepoetin alfa treatment on clinical outcomes in anemic patients with symptomatic heart failure: a preplanned pooled analysis of two randomized, double-blind, placebo-controlled trials
- Published in:
- 2006
- By:
- Publication type:
- Abstract
Dose equivalence between continuous erythropoietin receptor activator (CERA), Darbepoetin and Epoetin in patients with advanced chronic kidney disease.
- Published in:
- Hippokratia, 2014, v. 18, n. 4, p. 315
- By:
- Publication type:
- Article
DIALYSIS ANAEMIA.
- Published in:
- Nephrology Dialysis Transplantation, 2014, v. 29, n. suppl_3, p. iii491, doi. 10.1093/ndt/gfu176
- Publication type:
- Article
An observational cohort study of extended dosing (once every 2 weeks or once monthly) regimens with darbepoetin alfa in patients with chronic kidney disease not on dialysis: the EXTEND study.
- Published in:
- Nephrology Dialysis Transplantation, 2012, v. 27, n. 6, p. 2303, doi. 10.1093/ndt/gfr677
- By:
- Publication type:
- Article
Foreword.
- Published in:
- Nephrology Dialysis Transplantation, 2007, v. 22, n. suppl_4, p. iv1, doi. 10.1093/ndt/gfm159
- By:
- Publication type:
- Article
Extended dosing intervals with erythropoiesis-stimulating agents in chronic kidney disease: a review of clinical data.
- Published in:
- Nephrology Dialysis Transplantation, 2007, v. 22, n. suppl_4, p. iv19, doi. 10.1093/ndt/gfm162
- By:
- Publication type:
- Article
Pharmacology of darbepoetin alfa.
- Published in:
- Nephrology Dialysis Transplantation, 2007, v. 22, n. suppl_4, p. iv2, doi. 10.1093/ndt/gfm160
- By:
- Publication type:
- Article
Results of darbepoetin alfa treatment of anaemia in chemotherapy-receiving breast cancer patients: a single-centre retrospective observational study.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2021, v. 17, n. 6, p. 237, doi. 10.5603/OCP.2020.0048
- By:
- Publication type:
- Article
Effects of long- and short-term darbepoetin-α treatment on oxidative stress, inflammation and endothelial injury in ApoE knockout mice.
- Published in:
- Advances in Clinical & Experimental Medicine, 2017, v. 26, n. 4, p. 635, doi. 10.17219/acem/62834
- By:
- Publication type:
- Article
Switch from epoetin to darbepoetin alfa in hemodialysis: dose equivalence and hemoglobin stability.
- Published in:
- International Journal of Nephrology & Renovascular Disease, 2014, v. 7, p. 353, doi. 10.2147/IJNRD.S61895
- By:
- Publication type:
- Article
Greater potency of darbepoetin- α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.
- Published in:
- European Journal of Haematology, 2013, v. 90, n. 3, p. 237, doi. 10.1111/ejh.12067
- By:
- Publication type:
- Article
Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: a pilot study.
- Published in:
- 2017
- By:
- Publication type:
- journal article